Fenebrutinib met primary goals in two late-stage trials for the treatment of two different forms of multiple sclerosis.

Fox News host and meteorologist Janice Dean said she is taking a break from work to be with her family amid "health issues." ...

Roche Holding AG said a multiple sclerosis drug showed it could work for most forms of the disease in two late-stage trials, ...

Fox News host and meteorologist Janice Dean is taking a break from work and social media ’for a bit’ years after her multiple sclerosis diagnosis.

Aging and shifting hormone levels influence how MS changes over time, and the overlap of these factors during midlife can ...

Roche has reported wins for its BTK inhibitor fenebrutinib in a pair of phase 3 studies across two multiple sclerosis (MS) populations. One victory was based on the finding that the candidate was ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

Two Phase 3 trials testing the investigational oral therapy fenebrutinib in people with multiple sclerosis (MS) have hit ...

What are called autoimmune diseases can affect just about every part of the body — and tens of millions of people. While most ...

Dean was diagnosed with multiple sclerosis (MS) in 2005. “Multiple sclerosis is a disease that causes breakdown of the ...

Janice Dean explained why she's been missing from 'Fox & Friends' and said she's 'grateful' to supporters 'for the kind words ...

A wearable system that measures the brain's electrical activity can show how brain circuits are affected in people with MS, a ...